| Literature DB >> 22886525 |
Takeshi Hanagiri1, Shinji Shinohara, Masaru Takenaka, Yoshiki Shigematsu, Manabu Yasuda, Hidehiko Shimokawa, Yoshika Nagata, Makoto Nakagawa, Hidetaka Uramoto, Tomoko So, Fumihiro Tanaka.
Abstract
Hyaluronic acid (HA) has been proposed as a biochemical marker of malignant pleural mesothelioma (MPM). The present study focused on the implications of HA and CD44 interaction in the proliferation and invasiveness of MPM. The proliferation and invasive activity was evaluated in two human mesothelioma cell lines, ACC-MESO-1 and K921MSO, by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and the transwell chamber model. The knockdown of CD44 gene expression was accomplished by transfection of the cells with small interfering RNA. Flow cytometry revealed that both the ACC-MESO-1 and K921MSO cell lines highly expressed CD44. Treatment with HA enhanced the proliferation in both mesothelioma cell lines in comparison to cells without HA treatment. The treatment with HA (25 μg/ml) also significantly upregulated the invasion of both types of cells. The silencing of CD44 significantly abrogated the effect of HA treatment on the proliferation of ACC-MESO-1 cells and significantly suppressed the proliferation of K921MSO cells. HA-CD44 binding is important for the migration and proliferation of mesothelioma cells. Therefore, the HA-CD44 interaction is a potentially useful therapeutic target in MPM.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22886525 DOI： 10.1007/s13277-012-0473-5
Source DB: PubMed Journal: Tumour Biol ISSN： 1010-4283